Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

Reporting results of cancer treatment

1981 • 7,916 citations

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

2002 • 4,805 citations

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

Global cancer statistics in the year 2000

2001 • 2,471 citations

American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

2003 • 1,448 citations

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

2001 • 1,145 citations

Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

1997 • 668 citations

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

1997 • 590 citations

Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death

1999 • 579 citations

Structure and Utilization of Tubulin Isotypes

1988 • 474 citations

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

2004 • 344 citations

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

2005 • 324 citations

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer

2004 • 293 citations

Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients

2005 • 287 citations

Taxol Differentially Modulates the Dynamics of Microtubules Assembled from Unfractionated and Purified β-Tubulin Isotypes

1997 • 254 citations

Are tubulin isotypes functionally significant.

1993 • 250 citations

Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin.

1990 • 222 citations

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

2003 • 193 citations

Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies

1994 • 186 citations

Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung Cancer

2003 • 150 citations

Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.

1996 • 114 citations

Removal of .BETA.III Isotype Enhances Taxol Induced Microtubule Assembly.

1993 • 101 citations

Analysis of Tubulin Isotypes and Mutations from Taxol-Resistant Cells by Combined Isoelectrofocusing and Mass Spectrometry

2003 • 97 citations

Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study

2002 • 76 citations

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

2003 • 74 citations

Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism

2003 • 68 citations

Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs

1999 • 56 citations

Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients

2003 • 54 citations

MDR1/P-GP Expression as A Prognostic Factor in Acute Leukemias

1999 • 47 citations

Differential expression of tubulin isotypes during the cell cycle

1996 • 34 citations